Key Metrics
0.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
32
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q2
Hematology
SJR
- Q2 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.36
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
6 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Hemoglobin
- Immune thrombocytopenia
- Bortezomib
- Conventional chemotherapy
- Hematopoietic stem cell transplantation
- Blinatumomab
- Copanlisib
- Myelofibrosis
- Bruton's tyrosine kinase inhibitor
- Diffuse large B-cell lymphoma
- Ibrutinib
- Induction chemotherapy
- Interferon
- Ferritin
- Monoclonal antibody
- Proteasome inhibitor
- Severe Aplastic Anemia
- Donor lymphocyte infusion
- Bone marrow
- Acalabrutinib
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 7 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 7 |
| Article Processing Charges | USD 2300 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Therapeutic Advances in Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma.
- 1 Jan 24
- Therapeutic advances in hematology
-
Full paper
Research advances on short-chain fatty acids in gastrointestinal acute graft-versus-host disease.
- 1 Jan 24
- Therapeutic advances in hematology
-
Full paper
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
- 1 Jan 24
- Therapeutic advances in hematology
-
Full paper
An occurrence of eosinophilic folliculitis and alopecia associated with a sustained complete response to mogamulizumab in Sézary syndrome: a case report.
- 1 Jan 24
- Therapeutic advances in hematology
-
Full paper
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study.
- 1 Jan 24
- Therapeutic advances in hematology
-
Full paper
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis.
- 1 Jan 24
- Therapeutic advances in hematology
Scite analysis
Powered by scite_
515 articles received 7.7k citations see all
- 135 Supporting
- 7,315 Mentioning
- 22 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 3 Corrections
- 2 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
0%
4 to 6 months
60%
7 to 9 months
30%
Above 9 months
9%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Therapeutic Advances in Hematology been actively publishing?
Therapeutic Advances in Hematology has been in operation since 2010 till date.
What is the publishing frequency of Therapeutic Advances in Hematology ?
Therapeutic Advances in Hematology published with a Continuous publication frequency.
How many articles did Therapeutic Advances in Hematology publish last years ?
In 2023, Therapeutic Advances in Hematology published 51 articles.
What is the eISSN & pISSN for Therapeutic Advances in Hematology ?
For Therapeutic Advances in Hematology,eISSN is 2040-6215 and pISSN is2040-6207.
What is Citescore for Therapeutic Advances in Hematology ?
Citescore for Therapeutic Advances in Hematology is 0.7.
What is H index for Therapeutic Advances in Hematology ?
H index for Therapeutic Advances in Hematology is 32.
What is SNIP score for Therapeutic Advances in Hematology ?
SNIP score for Therapeutic Advances in Hematology is 0.36.
What is the SJR for Therapeutic Advances in Hematology ?
SJR for Therapeutic Advances in Hematology is Q2.
Who is the publisher of Therapeutic Advances in Hematology ?
SAGE PUBLICATIONS LTD is the publisher of Therapeutic Advances in Hematology.